CIK 0000879169
- Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943136539
- Phone
- +1 302-498-6700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- 4 Grant or award Director acquired 3,284 shares (grant or award)
- 4 Grant or award Director acquired 1,642 shares (grant or award)
- 4 Grant or award Director acquired 1,642 shares (grant or award)
- 4 Grant or award Director acquired 1,642 shares (grant or award)
- 4 Grant or award Director acquired 1,642 shares (grant or award)
- 4 Grant or award Director acquired 1,642 shares (grant or award)
- 4 Grant or award Director acquired 1,642 shares (grant or award)
- 4 Planned sale Principal Accounting Officer sold 2,639 shares at $100.00 ($263,900)
- 4 Shares withheld for taxes President, Global Head of R&D gave up 25,469 shares (to pay taxes)
- 4 Planned sale Principal Accounting Officer sold 2,051 shares at $97.35 ($199,665)
- 4 Shares withheld for taxes Director gave up 13,059 shares (to pay taxes)
- 4 Planned sale Director sold 15,000 shares at $94.93 ($1,423,950)
- 4/A Grant or award CMO & Head of Late-Stage Dev. acquired 44,124 shares (grant or award)
- 4/A Grant or award President, Global Head of R&D acquired 31,517 shares (grant or award)
- 4 Exercise or conversion Director acquired 30,000 shares (option exercise)
- 4 Grant or award EVP & Chief Financial Officer acquired 26,343 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale President, Global Head of R&D sold 18,667 shares at $96.50 ($1,801,366)
- 4 Exercise or conversion Chief Executive Officer acquired 125,000 shares (option exercise)
- 4 Grant or award President, Global Head of R&D acquired 27,892 shares (grant or award)
Page 3 of 82 · 1,626 filings